Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe study location list has been updated to 130 sites, with new centers in Sichuan, Charlotte, Tampa, and Singapore, among others. Several locations were removed, including Antwerp University Hospital, Sichuan Provincial Cancer Hospital, TU Dresden, Gdańsk, and the National Cancer Centre.SummaryDifference0.7%

- Check9 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check16 days agoChange DetectedNote added that PubMed-generated publications are automatically filled and may not relate to the study. Revision label updated to v3.3.1; the previous PubMed note and v3.2.0 revision have been removed.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded Tainan, Taiwan, 70457 to the Locations and removed Tainan City, Taiwan, 70457; the government funding lapse notice text in the page header was deleted.SummaryDifference0.2%

- Check38 days agoChange DetectedThe new screenshot shows only minor UI updates and no changes to core study content like eligibility criteria, primary outcomes, enrollment, or locations; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check66 days agoChange Detected- Added a government funding notice and operating status guidance, plus a v3.2.0 revision tag. - Removed the term 'Ovarian cancer' and an older v3.0.2 revision tag. If ovarian cancer was part of the core content, its removal could affect topic scope, but overall the page now emphasizes current status and updated version.SummaryDifference2%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.